PRIMARY DOCUMENT

Company

PTC THERAPEUTICS, INC.

Filed

October 30, 2023

Accession Number

0001654954-23-013525

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →